Trial Profile
Efficacy of combination therapy of sitagliptin and low-dose glimepiride in patients with type 2 diabetes mellitus inadequately controlled with high-dose glimepiride
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Jul 2014 New trial record